menu
    • menu

    Company profile for Kyverna Therapeutics

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a cell therapy company developing a new class of treatments and potential cures for serious autoimmune diseases. Autoimmune diseases result from a failure of the immune system to distinguish self from non-self, caused by autoreactive B cells and T cells attacking the body’s own tissues. Kyverna’s therapeutic strategy combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate th...
    We are a cell therapy company developing a new class of treatments and potential cures for serious autoimmune diseases. Autoimmune diseases result from a failure of the immune system to distinguish self from non-self, caused by autoreactive B cells and T cells attacking the body’s own tissues. Kyverna’s therapeutic strategy combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate these autoreactive immune cells at the root cause of inflammatory disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kyverna TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    740 Heinz Avenue Berkeley, CA 94710
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kyvernatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kyverna/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kyverna Therapeutics Appoints Greg Martini as CFO
    Kyverna Therapeutics Appoints Greg Martini as CFO

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296545/0/en/kyverna-therapeutics-names-greg-martini-as-chief-financial-officer.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Kyverna Therapeutics To Present At Upcoming Investor Conferences
    Kyverna Therapeutics To Present At Upcoming Investor Conferences

    14 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/14/3294836/0/en/kyverna-therapeutics-to-present-at-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    14 May 2026
    Share Share
    Kyverna Therapeutics Initiates Rolling SPS BLA, Reports Q1 2026
    Kyverna Therapeutics Initiates Rolling SPS BLA, Reports Q1 2026

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293353/0/en/kyverna-therapeutics-announces-initiation-of-rolling-sps-bla-submission-and-reports-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Kyverna Therapeutics Names Nadia Dac as Chief Commercial Officer
    Kyverna Therapeutics Names Nadia Dac as Chief Commercial Officer

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286654/0/en/kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Kyverna's Full SPS Data Sets Stage for First Autoimmune CAR-T Nod
    Kyverna's Full SPS Data Sets Stage for First Autoimmune CAR-T Nod

    21 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/racing-toward-first-fda-nod-autoimmune-car-t-kyverna-bolsters-lead-full-sps-dataset

    FIERCE BIOTECH
    21 Apr 2026
    Share Share
    Kyverna Therapeutics Hosts Neuroimmunology Franchise Data Call
    Kyverna Therapeutics Hosts Neuroimmunology Franchise Data Call

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270858/0/en/Kyverna-Therapeutics-to-Host-Conference-Call-on-New-Data-Across-Neuroimmunology-Franchise-at-AAN-2026.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search